Back to Search
DAVID BROWN, PH.D
PH.D
Marriage & Family Therapist
NPI: 1467578427Individual
Specialties, Licenses & Credentials
Marriage & Family TherapistPrimary
Marriage & Family Therapist
Code: 106H00000X
LMFT-0148(AZ)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial).
PMID 24518078·Br J Ophthalmol·2014
4-observational
Aflibercept (eylea) for age-related macular degeneration.
PMID 22354219·Med Lett Drugs Ther·2012
6-review
Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration.
PMID 22300011·Expert Opin Pharmacother·2012
6-review
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
PMID 21526923·N Engl J Med·2011
4-observational
Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
PMID 21055816·Ophthalmology·2011
8-other
Vascular endothelial growth factor Trap-Eye for diabetic macular oedema.
PMID 19174397·Br J Ophthalmol·2009
8-other
Predicted biological activity of intravitreal VEGF Trap.
PMID 18356264·Br J Ophthalmol·2008
4-observational
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
PMID 17386270·Am J Ophthalmol·2007
3-trial
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
PMID 17021319·N Engl J Med·2006
4-observational
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
PMID 16458968·Ophthalmology·2006
5-case
Cystoid macular degeneration in chronic central serous chorioretinopathy.
PMID 12652224·Retina·2003
8-other
VEGF-Trap: a VEGF blocker with potent antitumor effects.
PMID 12177445·Proc Natl Acad Sci U S A·2002
7-preclinical
Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
PMID 11927845·Retina·2002
3-trial
Analysis of pH gradients resulting from mass transport limitations in engineered heart tissue.
PMID 17680364·Ann Biomed Eng·2007
7-preclinical
N-methyl-D-aspartate receptor (NMDA) antagonists as potential pain therapeutics.
PMID 16719815·Curr Top Med Chem·2006
6-review
A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis.
PMID 15454231·Bioorg Med Chem Lett·2004
7-preclinical
Synthesis of 7-chloro-2,3-dihydro-2-[1-(pyridinyl)alkyl]-pyridazino[4,5-b]quinoline-1,4,10(5H)-triones as NMDA glycine-site antagonists.
PMID 14505669·Bioorg Med Chem Lett·2003
8-other
Deaths associated with platelet glycoprotein IIb/IIIa inhibitor treatment.
PMID 12695459·Heart·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4447 E BROADWAY RD STE 108
MESA, AZ 85206 - Phone
- (480) 641-9700
Quick Facts
- NPI
- 1467578427
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile